Nektar Therapeutics And Canopy Growth On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Nektar Therapeutics, Nova Lifestyle, and Transocean.

Rank Financial Asset Price Change Updated (EST)
1 Nektar Therapeutics (NKTR) 0.65 11.61% 2023-09-11 19:47:07
2 Nova Lifestyle (NVFY) 2.79 8.14% 2023-09-11 22:41:08
3 Transocean (RIG) 8.69 7.08% 2023-09-12 12:59:23
4 Nexstar Media Group (NXST) 142.98 6.76% 2023-09-11 23:10:07
5 Full House Resorts (FLL) 4.95 6.22% 2023-09-12 13:27:54
6 AMC (AMC) 7.78 6.02% 2023-09-12 13:34:37
7 PNC Financial Services Group (PNC) 124.57 5.55% 2023-09-12 13:38:29
8 Neonode (NEON) 1.77 5.36% 2023-09-11 19:15:07
9 Pacific Biosciences of California (PACB) 10.94 5.35% 2023-09-12 13:29:56
10 3D Systems (DDD) 5.30 5.23% 2023-09-12 12:54:55

The three biggest losers today are Canopy Growth, Neptune Wellness Solutions, and Oracle.

Rank Financial Asset Price Change Updated (EST)
1 Canopy Growth (CGC) 1.34 -21.01% 2023-09-12 13:40:00
2 Neptune Wellness Solutions (NEPT) 6.02 -16.27% 2023-09-11 19:23:08
3 Oracle (ORCL) 108.17 -14.63% 2023-09-12 12:58:37
4 Tilray (TLRY) 2.98 -9.97% 2023-09-12 13:33:38
5 Northwest Biotherapeutics (NWBO) 0.64 -7.1% 2023-09-11 22:44:07
6 Cronos Group (CRON) 2.25 -6.46% 2023-09-12 13:32:04
7 Nikola (NKLA) 0.85 -6.3% 2023-09-12 10:33:31
8 Northern Trust (NTRS) 72.75 -5.62% 2023-09-12 13:29:44
9 Pathfinder Bancorp (PBHC) 13.03 -5.44% 2023-09-12 05:06:07
10 Netlist (NLST) 1.61 -5.29% 2023-09-11 19:48:07

Winners today

1. Nektar Therapeutics (NKTR) – 11.61%

Nektar Therapeutics operates as a biopharmaceutical company. The company researches and develops pipeline of investigational medicines in oncology, immunology, and virology, as well as a portfolio of approved partnered medicines. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of non-small cell lung cancer and immuno-oncology; and phase 1B clinical trial to treat COVID-19.It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat locally advanced or metastatic solid tumor malignancies, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.

NASDAQ ended the session with Nektar Therapeutics jumping 11.61% to $0.65 on Tuesday, following the last session’s upward trend. NASDAQ slid 1.04% to $13,773.61, after two consecutive sessions in a row of gains, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Nektar Therapeutics has a trailing twelve months EPS of $-1.59.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -93.6%.

More news about Nektar Therapeutics.

2. Nova Lifestyle (NVFY) – 8.14%

Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living rooms, dining rooms, bedrooms, and home offices. Its products include sofas, chairs, dining tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinics, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.

NASDAQ ended the session with Nova Lifestyle rising 8.14% to $2.79 on Tuesday while NASDAQ dropped 1.04% to $13,773.61.

Earnings Per Share

As for profitability, Nova Lifestyle has a trailing twelve months EPS of $-9.57.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.02%.

More news about Nova Lifestyle.

3. Transocean (RIG) – 7.08%

Transocean Ltd., together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide. It contracts its mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells. It serves integrated energy companies, government-owned or government-controlled energy companies, and other independent energy companies. Transocean Ltd. was founded in 1926 and is based in Steinhausen, Switzerland.

NYSE ended the session with Transocean jumping 7.08% to $8.69 on Tuesday, following the last session’s downward trend. NYSE rose 0.03% to $15,953.91, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Transocean has a trailing twelve months EPS of $-1.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.34%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Transocean’s stock is considered to be oversold (<=20).

More news about Transocean.

4. Nexstar Media Group (NXST) – 6.76%

Nexstar Media Group, Inc., a television broadcasting and digital media company, focuses on the acquisition, development, and operation of television stations and interactive community websites and digital media services in the United States. The company offers free programming to television viewing audiences. As of December 31, 2020, it provided sales, programming, and other services through various local service agreements to 37 power television stations owned by independent third parties; and owned, operated, programmed, or provided sales and other services to 198 television stations. The company also offers video and display advertising platforms that are delivered locally or nationally through its own and various third party websites and mobile applications, as well as owns WGN America, a national general entertainment cable network. Its stations are affiliates of ABC, NBC, FOX, CBS, The CW, MyNetworkTV, and other broadcast television networks. The company was formerly known as Nexstar Broadcasting Group, Inc. and changed its name to Nexstar Media Group, Inc. in January 2017. Nexstar Media Group, Inc. was founded in 1996 and is headquartered in Irving, Texas.

NASDAQ ended the session with Nexstar Media Group rising 6.76% to $142.98 on Tuesday, after two sequential sessions in a row of gains. NASDAQ fell 1.04% to $13,773.61, after two sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Nexstar Media Group has a trailing twelve months EPS of $18.23.

PE Ratio

Nexstar Media Group has a trailing twelve months price to earnings ratio of 7.84. Meaning, the purchaser of the share is investing $7.84 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.14%.

Sales Growth

Nexstar Media Group’s sales growth is negative 8.6% for the ongoing quarter and negative 9.6% for the next.

Moving Average

Nexstar Media Group’s worth is way under its 50-day moving average of $167.77 and way below its 200-day moving average of $173.64.

More news about Nexstar Media Group.

5. Full House Resorts (FLL) – 6.22%

Full House Resorts, Inc. owns, develops, invests in, operates, manages, and leases casinos, and related hospitality and entertainment facilities in the United States. The company owns and operates the Silver Slipper Casino and Hotel in Hancock County, Mississippi; Bronco Billy's Casino and Hotel in Cripple Creek, Colorado; Rising Star Casino Resort in Rising Sun, Indiana; Stockman's Casino in Fallon, Nevada; Grand Lodge Casino in Incline Village, Nevada; and American Place / The Temporary in Waukegan, Illinois. It also operates online sports wagering websites. Full House Resorts, Inc. was incorporated in 1987 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Full House Resorts rising 6.22% to $4.95 on Tuesday while NASDAQ fell 1.04% to $13,773.61.

Earnings Per Share

As for profitability, Full House Resorts has a trailing twelve months EPS of $-0.82.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.46%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 30% and 40%, respectively.

Sales Growth

Full House Resorts’s sales growth is 44.3% for the present quarter and 84.5% for the next.

More news about Full House Resorts.

6. AMC (AMC) – 6.02%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC jumping 6.02% to $7.78 on Tuesday, following the last session’s upward trend. NYSE rose 0.03% to $15,953.91, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-5.07.

Yearly Top and Bottom Value

AMC’s stock is valued at $7.78 at 17:32 EST, way below its 52-week low of $12.40.

Volume

Today’s last reported volume for AMC is 30845400 which is 199.52% above its average volume of 10298300.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 70.6% and 78.6%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AMC’s stock is considered to be overbought (>=80).

More news about AMC.

7. PNC Financial Services Group (PNC) – 5.55%

The PNC Financial Services Group, Inc. operates as a diversified financial services company in the United States. It operates through three segments: Retail Banking, Corporate & Institutional Banking, and Asset Management Group segments. The company's Retail Banking segment offers checking, savings, and money market accounts, as well as certificates of deposit; residential mortgages, home equity loans and lines of credit, auto loans, credit cards, education loans, and personal and small business loans and lines of credit; and brokerage, insurance, and investment and cash management services. This segment serves consumer and small business customers through a network of branches, ATMs, call centers, and online and mobile banking channels. Its Corporate & Institutional Banking segment provides secured and unsecured loans, letters of credit, and equipment leases; cash and investment management services, receivables and disbursement management services, funds transfer services, international payment services, and access to online/mobile information management and reporting; securities underwriting, loan syndications, customer-related trading, and mergers and acquisitions and equity capital markets advisory related services; and commercial loan servicing and technology solutions. It serves mid-sized and large corporations, and government and not-for-profit entities. The company's Asset Management Group segment offers investment and retirement planning, customized investment management, credit and cash management solutions, and trust management and administration services for high net worth and ultra high net worth individuals, and their families; and multi-generational family planning services for ultra high net worth individuals and their families. It also provides outsourced chief investment officer, custody, private real estate, cash and fixed income client solutions, and fiduciary retirement advisory services for institutional clients. The company was founded in 1852 and is headquartered in Pittsburgh, Pennsylvania.

NYSE ended the session with PNC Financial Services Group jumping 5.55% to $124.57 on Tuesday while NYSE jumped 0.03% to $15,953.91.

Earnings Per Share

As for profitability, PNC Financial Services Group has a trailing twelve months EPS of $14.58.

PE Ratio

PNC Financial Services Group has a trailing twelve months price to earnings ratio of 8.54. Meaning, the purchaser of the share is investing $8.54 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.15%.

Volatility

PNC Financial Services Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.01%, a negative 0.54%, and a positive 1.22%.

PNC Financial Services Group’s highest amplitude of average volatility was 1.68% (last week), 1.17% (last month), and 1.22% (last quarter).

Volume

Today’s last reported volume for PNC Financial Services Group is 3621780 which is 67.54% above its average volume of 2161720.

More news about PNC Financial Services Group.

8. Neonode (NEON) – 5.36%

Neonode Inc., together with its subsidiaries, develops optical sensing solutions for contactless touch, touch, gesture sensing, and in-cabin monitoring in the United States, Japan, South Korea, China, and internationally. The company also licenses its technology to original equipment manufacturers (OEMs) and Tier 1 suppliers. In addition, it provides embedded sensors to OEMs, original design manufacturers, and Tier 1 suppliers. Further, the company sells Neonode branded sensor products, such as AirBar products through distributors. Additionally, it provides engineering consulting services. Neonode Inc. was incorporated in 1997 and is headquartered in Stockholm, Sweden.

NASDAQ ended the session with Neonode jumping 5.36% to $1.77 on Tuesday, following the last session’s upward trend. NASDAQ dropped 1.04% to $13,773.61, after two successive sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Neonode has a trailing twelve months EPS of $-0.32.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.7%.

Sales Growth

Neonode’s sales growth is 64.5% for the ongoing quarter and 7% for the next.

Yearly Top and Bottom Value

Neonode’s stock is valued at $1.77 at 17:32 EST, way under its 52-week high of $14.75 and higher than its 52-week low of $1.64.

More news about Neonode.

9. Pacific Biosciences of California (PACB) – 5.35%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California jumping 5.35% to $10.94 on Tuesday, after five successive sessions in a row of losses. NASDAQ dropped 1.04% to $13,773.61, after two consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.22%.

More news about Pacific Biosciences of California.

10. 3D Systems (DDD) – 5.23%

3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.

NYSE ended the session with 3D Systems jumping 5.23% to $5.30 on Tuesday while NYSE jumped 0.03% to $15,953.91.

Earnings Per Share

As for profitability, 3D Systems has a trailing twelve months EPS of $-0.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.22%.

More news about 3D Systems.

Losers Today

1. Canopy Growth (CGC) – -21.01%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth sliding 21.01% to $1.34 on Tuesday while NASDAQ dropped 1.04% to $13,773.61.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-3.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 405.71M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canopy Growth’s EBITDA is 1.84.

Moving Average

Canopy Growth’s value is way higher than its 50-day moving average of $0.49 and way under its 200-day moving average of $1.82.

Sales Growth

Canopy Growth’s sales growth for the current quarter is negative 10.6%.

More news about Canopy Growth.

2. Neptune Wellness Solutions (NEPT) – -16.27%

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

NASDAQ ended the session with Neptune Wellness Solutions falling 16.27% to $6.02 on Tuesday while NASDAQ fell 1.04% to $13,773.61.

Earnings Per Share

As for profitability, Neptune Wellness Solutions has a trailing twelve months EPS of $-180.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -818.48%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Neptune Wellness Solutions’s EBITDA is 0.65.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 1208.8% and a negative 3190.5%, respectively.

Yearly Top and Bottom Value

Neptune Wellness Solutions’s stock is valued at $6.02 at 17:32 EST, way below its 52-week high of $95.60 and way above its 52-week low of $4.40.

Volume

Today’s last reported volume for Neptune Wellness Solutions is 159897 which is 28.18% above its average volume of 124740.

More news about Neptune Wellness Solutions.

3. Oracle (ORCL) – -14.63%

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing. The company also offers cloud-based industry solutions for various industries; Oracle application licenses; and Oracle license support services. In addition, it provides cloud and license business' infrastructure technologies, such as the Oracle Database and MySQL Database; Java, a software development language; and middleware, including development tools and others. The company's cloud and license business' infrastructure technologies also comprise cloud-based compute, storage, and networking capabilities; and Oracle autonomous database, MySQL HeatWave, Internet-of-Things, digital assistant, and blockchain. Further, it provides hardware products and other hardware-related software offerings, including Oracle engineered systems, enterprise servers, storage solutions, industry-specific hardware, virtualization software, operating systems, management software, and related hardware services; and consulting and customer services. The company markets and sells its cloud, license, hardware, support, and services offerings directly to businesses in various industries, government agencies, and educational institutions, as well as through indirect channels. Oracle Corporation was founded in 1977 and is headquartered in Austin, Texas.

NYSE ended the session with Oracle sliding 14.63% to $108.17 on Tuesday while NYSE jumped 0.03% to $15,953.91.

: U.S. stocks open lower as tech shares retreat after oracle earnings; investors await Apple event, inflation dataU.S. stock indexes opened lower on Tuesday after starting the week on a strong footing, with disappointing guidance from Oracle weighing on technology stocks.

: oracle stock dives toward worst day in 2 decades after disappointing earnings reportShares of Oracle Corp. have accelerated to the downside after the opening bell, and is not on course to suffer their worst one-day performance in 21 years.

Earnings Per Share

As for profitability, Oracle has a trailing twelve months EPS of $3.07.

PE Ratio

Oracle has a trailing twelve months price to earnings ratio of 35.23. Meaning, the purchaser of the share is investing $35.23 for every dollar of annual earnings.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Oracle’s EBITDA is 65.57.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jul 10, 2023, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 1.27%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on 49.95B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 3.9% and 3.3%, respectively.

Previous days news about Oracle

  • Oracle (orcl) Q1 earnings top estimates. According to Zacks on Monday, 11 September, "While Oracle has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
  • Oracle (orcl) Q1 earnings: taking a look at key metrics versus estimates. According to Zacks on Monday, 11 September, "For the quarter ended August 2023, Oracle (ORCL Quick QuoteORCL – Free Report) reported revenue of $12.45 billion, up 8.8% over the same period last year. ", "Here is how Oracle performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
  • Oracle shares sink after hours following disappointing revenue outlook. According to MarketWatch on Monday, 11 September, "Oracle shares, which had been down about 5% after hours when its earnings call started, dropped more than 9% after Oracle Chief Executive Safra Catz forecast its outlook for the quarter."

More news about Oracle.

4. Tilray (TLRY) – -9.97%

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

NASDAQ ended the session with Tilray dropping 9.97% to $2.98 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ slid 1.04% to $13,773.61, after two successive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Tilray has a trailing twelve months EPS of $-2.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.14%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Tilray’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for Tilray is 50854000 which is 75.89% above its average volume of 28912200.

More news about Tilray.

5. Northwest Biotherapeutics (NWBO) – -7.1%

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

NASDAQ ended the session with Northwest Biotherapeutics dropping 7.1% to $0.64 on Tuesday, after two sequential sessions in a row of losses. NASDAQ fell 1.04% to $13,773.61, after two consecutive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Northwest Biotherapeutics has a trailing twelve months EPS of $-0.08.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Northwest Biotherapeutics’s EBITDA is 397.

Yearly Top and Bottom Value

Northwest Biotherapeutics’s stock is valued at $0.64 at 17:32 EST, way under its 52-week high of $1.27 and way above its 52-week low of $0.40.

Moving Average

Northwest Biotherapeutics’s worth is way higher than its 50-day moving average of $0.54 and below its 200-day moving average of $0.65.

More news about Northwest Biotherapeutics.

6. Cronos Group (CRON) – -6.46%

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

NASDAQ ended the session with Cronos Group sliding 6.46% to $2.25 on Tuesday, after three successive sessions in a row of gains. NASDAQ slid 1.04% to $13,773.61, after two successive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Cronos Group has a trailing twelve months EPS of $-0.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.1%.

Moving Average

Cronos Group’s value is way above its 50-day moving average of $1.85 and above its 200-day moving average of $2.16.

Yearly Top and Bottom Value

Cronos Group’s stock is valued at $2.25 at 17:32 EST, way below its 52-week high of $3.62 and way higher than its 52-week low of $1.64.

Revenue Growth

Year-on-year quarterly revenue growth declined by 11.9%, now sitting on 86.11M for the twelve trailing months.

Sales Growth

Cronos Group’s sales growth is negative 19.1% for the present quarter and negative 8.9% for the next.

More news about Cronos Group.

7. Nikola (NKLA) – -6.3%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola sliding 6.3% to $0.85 on Tuesday while NASDAQ fell 1.04% to $13,773.61.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.26.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -132.55%.

More news about Nikola.

8. Northern Trust (NTRS) – -5.62%

Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Northern Trust dropping 5.62% to $72.75 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ dropped 1.04% to $13,773.61, after two sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Northern Trust has a trailing twelve months EPS of $5.58.

PE Ratio

Northern Trust has a trailing twelve months price to earnings ratio of 13.04. Meaning, the purchaser of the share is investing $13.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.72%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 14.4% and positive 114.1% for the next.

Sales Growth

Northern Trust’s sales growth is 0.2% for the ongoing quarter and 15.6% for the next.

Yearly Top and Bottom Value

Northern Trust’s stock is valued at $72.75 at 17:32 EST, way below its 52-week high of $100.74 and higher than its 52-week low of $69.54.

More news about Northern Trust.

9. Pathfinder Bancorp (PBHC) – -5.44%

Pathfinder Bancorp, Inc. operates as a holding company for Pathfinder Bank that provides various banking and financial products and services primarily in Oswego and Onondaga Counties, New York. The company accepts various deposits, including checking, savings, and money market deposit accounts, as well as certificates of deposit, and demand and time deposits. Its loan portfolio comprises commercial real estate loans; commercial loans; residential real estate and construction loans; tax-exempt loans; home equity loans and junior liens; municipal loans; and consumer loans comprising automobile, recreational vehicles, and unsecured personal loans, as well as unsecured lines of credit and loans secured by deposit accounts. The company is also involved in the property, casualty, and life insurance brokerage business. It primarily serves individuals, families, small to mid-size businesses, and municipalities. As of February 03, 2022, it operated through ten full-service offices located in Oswego and Onondaga Counties, as well as one limited purpose office located in Oneida County. Pathfinder Bancorp, Inc. was founded in 1859 and is headquartered in Oswego, New York.

NASDAQ ended the session with Pathfinder Bancorp dropping 5.44% to $13.03 on Tuesday, following the last session’s downward trend. NASDAQ fell 1.04% to $13,773.61, after two sequential sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Pathfinder Bancorp has a trailing twelve months EPS of $1.85.

PE Ratio

Pathfinder Bancorp has a trailing twelve months price to earnings ratio of 7.04. Meaning, the purchaser of the share is investing $7.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.24%.

More news about Pathfinder Bancorp.

10. Netlist (NLST) – -5.29%

Netlist, Inc. designs, manufactures, and sells modular memory subsystems for the server, high-performance computing, and communications markets worldwide. It offers HybriDIMM, a storage class memory product, which unifies dynamic random access memory (DRAM) and NAND flash in a plug-and-play module delivering terabyte storage capacities operating at nanosecond memory speeds. The company also provides nonvolatile (NV) memory products, such as NVvault DDR4 NVDIMM that provides data acceleration and protection in a joint electron device engineering council standard DDR4 interface; and specialty DIMMs and embedded flash products for use in data center and industrial applications. It resells solid state drive (SSD), NAND flash, DRAM products, and other component products to storage customers, appliance customers, system builders, and cloud and datacenter customers; and sells component inventory to distributors and other users of memory integrated circuits. The company markets and sells its products primarily to original equipment manufacturers through a direct sales force and a network of independent sales representatives. Netlist, Inc. was incorporated in 2000 and is headquartered in Irvine, California.

NASDAQ ended the session with Netlist sliding 5.29% to $1.61 on Tuesday, after four successive sessions in a row of losses. NASDAQ fell 1.04% to $13,773.61, after two sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Netlist has a trailing twelve months EPS of $-0.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -150.54%.

Moving Average

Netlist’s worth is way below its 50-day moving average of $2.87 and way below its 200-day moving average of $2.85.

Revenue Growth

Year-on-year quarterly revenue growth declined by 81.9%, now sitting on 75.13M for the twelve trailing months.

More news about Netlist.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *